The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness of pazopanib as first-line treatment of metastatic renal cell carcinoma from National Health Service United Kingdom perspective.
 
Barbara Elizabeth Ratto
Employment - Novartis; Novartis (I)
Stock and Other Ownership Interests - Novartis
Research Funding - Novartis (I); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Ankur Khare
Employment - Novartis
 
Kapil Gudala
Employment - Novartis
 
Praveen Gunda
Employment - Novartis